Increase in hematocrit, hemoglobin and red cell mass in normal mice after treatment with cyclic AMP  (38543).
Chronic treatment of normal mice with either dibutyryl cyclic AMP or erythropoietin produced elevations in the hematocrit, hemoglobin concentration and red cell mass when compared to these same hematological parameters in untreated mice.  Dibutyryl cyclic AMP increased red cell mass by 46% while ESF treatment resulted in a 56% increase in red cell mass.  These studies confirm earlier reports of the effects of cyclic AMP in increasing radioactive iron incorporation into red cells and further indicate that this change is associated with an absolute increase renal cyclic AMP concentrations probably stimulate erythropoiesis as a consequence of increased kidney production of erythropoietin.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology*; D004912:Erythrocytes; D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000494:pharmacology; D006400:Hematocrit; D006452:Hemoglobinometry; D008297:Male; D051379:Mice; D013268:Stimulation, Chemical
D004921:Erythropoietin; D003994:Bucladesine; D000242:Cyclic AMP